Global Diabetic Retinopathy Market 2015-2019

MUMBAI, June 22, 2015 /PRNewswire/ --

Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease. Laser surgery, injection of corticosteroids or anti-VEGF drugs into the eye, and vitrectomy are some of the available treatments. One feature of diabetic retinopathy is diabetic macular edema. This is a serious medical condition involving leakage of fluid from the minute, delicate, and previously injured blood vessels located at the back of the eye, which then collects in the macula. This results in inflammation of tissue and blurry vision.

Covered in this Report 

This report covers the present scenario and the growth prospects of the global diabetic retinopathy market for the period 2015-2019. To calculate the market size, the report considers revenue from the sales of prescribed as well as off-label drugs available in the market.

The report also presents the vendor landscape and a corresponding detailed analysis of the four major vendors in the market. In addition, it discusses the major drivers that influence the growth and the challenges faced by the vendors and the market at large, as well as the key trends that contribute to the growth the market.

Global Diabetic Retinopathy Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the global diabetic retinopathy market landscape and its growth prospects in the coming years.

Read more & request for sample page: 

https://www.bharatbook.com/healthcare-market-research-reports-504043/global-diabetic-retinopathy-.html

The report also includes a discussion of the key vendors operating in this market.

Key Regions 

• Americas
• APAC
• EMEA

Key Vendors 

• Bayer
• F. Hoffmann-La Roche
• Novartis
• Regeneron Pharmaceuticals

Other Prominent Vendors 

• Actavis
• Alimera Sciences
• Ampio Pharmaceuticals
• BCN Peptides
• Boehringer Ingelheim
• Glycadia
• iCo Therapeutics
• Isis Pharmaceuticals
• Kowa Group
• Lpath
• Numoda Capital
• Ohr Pharmaceutical
• OPKO Health
• Parexel International
• Promedior
• pSivida
• Quark Pharmaceuticals
• R-Tech Ueno
• Sirnaomics
• ThromboGenics

Market Driver 

• Growth in patient population

Market Challenge 

• Availability of effective surgical treatments

Market Trend 

• Launch of novel agents

Key Questions Answered in this Report 

• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Table Of Contents 

1. Executive Summary 

2. List of Abbreviations 

3. Scope of the Report 

- Market Overview

- Product Offerings

- Product Profiles

- Lucentis

- Eylea

4. Market Research Methodology 

- Market Research Process

- Research Methodology

5. Introduction 

6. Disease Overview 

7. Market Landscape 

8. Pipeline Portfolio 

9. Market Segmentation by Type of Molecule 

10. Market Segmentation by Route of Administration 

11. Geographical Segmentation 

12. Buying Criteria 

13. Market Growth Drivers 

14. Drivers and their Impact 

15. Market Challenges 

16. Impact of Drivers and Challenges 

17. Market Trends 

18. Trends and their Impact 

19. Vendor Landscape 

- Competitive Scenario

- Key News

- Mergers and Acquisitions

- Market Share Analysis 2014

- Novartis

- F. Hoffmann-La Roche

- Regeneron Pharmaceuticals

- Bayer

- Other and Future Prominent Vendors

20. Key Vendor Analysis 

- F. Hoffmann-La Roche

- Novartis

- Regeneron Pharmaceuticals

21. Other Reports in this Series 

Related Reports 

• Global Diabetic Retinopathy Industry 2015 Market Research Report
• Retinopathy Partnering 2010-2015
• Diabetic Nephropathy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
• Global Disposable vacuum blood vessels Industry 2014 Market Research Report

About Bharat Book Bureau 

Bharat Book Bureau is the leading market research information aggregator that provides market research reports, industry analysis, company profiles, business reports, country reports, newsletters and online databases. Our clients include Corporate, Consulting firms, and Academic Institutions and Government departments across the globe. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. The market research reports we provide, help global companies examine the different markets before setting up a business or expanding into different countries across the world. They give a complete perspective on the current market scenario, trends, segments and future outlook.

Contact Details:
Poonam
Bharat Book Bureau
India: +91-22-27810772, 27810773
Blog: https://www.bharatbook.com/blog/
W: https://www.bharatbook.com/
E: poonam@bharatbook.com